Barclays assigned a Bearish rating to Oscar Health on July 3, 2025.
3 reports, 1 independent
Updated Aug 7
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays assigned a Bearish rating to Oscar Health on July 3, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies and Barclays issued positive rating changes and target price boosts for Oscar Health.1 source
- Barclays assigned a Bearish rating to Oscar Health.
Keep exploring
The entities involved
-
Oscar Health
U.S. health insurance company
Nothing else this week.
-
Barclays
British bank
- QinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.
- Financial institutions provided ratings on multiple companies on July 8, 2026, including Goldman Sachs reiterating Tesla as neutral, Barclays initiating Toast as overweight, and Bank of America rating Nvidia as a buy.
Related events
- Barclays issued rating and price objective reports for Ubiquiti on August 1, 2026.
- Morgan Stanley reaffirmed an overweight rating on AbbVie, and Barclays raised its price objective on September 10, 2026.
- Barclays reiterated an overweight rating on the stock of Brighthouse Financial.
- MarketBeat has released analyst ratings and financial comparisons for two large-cap finance companies: East West Bancorp and Barclays.
- Oscar Health and CVS Health are identified as health insurance providers in the market segment.
Coverage
Newest first; wire copies grouped- tickerreport.com
- Unknown outlet
- Unknown outlet